Surgical treatment of recurrent ovarian cancer: report of 21 cases and a review of the literature

被引:32
作者
Cormio, G [1 ]
di Vagno, G [1 ]
Cazzolla, A [1 ]
Bettocchi, S [1 ]
di Gesu', G [1 ]
Loverro, G [1 ]
Selvaggi, L [1 ]
机构
[1] Univ Bari, Gynecol Oncol Unit, Bari, Italy
来源
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY | 1999年 / 86卷 / 02期
关键词
recurrent ovarian carcinoma; secondary cytoreductive surgery;
D O I
10.1016/S0301-2115(99)00067-6
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Aim: To evaluate the role of secondary cytoreductive surgery in patients with recurrent ovarian cancer. Patients and methods: A retrospective chart review was conducted on 21 patients submitted to secondary cytoreductive surgery for apparently isolated and resectable recurrence of ovarian cancer, after a disease-free interval of at least 12 months. Results: Fifteen patients (71%) had complete surgical debulking with no macroscopic tumor at the completion of the surgical procedure. Eight patients (38%) required an intestinal resection but no colostomy was performed. Eleven complications were recorded in nine patients, but no operative death occurred. The median survival time for all patients after diagnosis of recurrent disease was 29 months (range 6-96 months). Survival time after diagnosis of recurrence was not significantly related either to known prognostic factors of ovarian cancer or to the length of the clinical remission time. The absence of residual disease after salvage surgery was the only factory associated with prolonged survival. Conclusion: Secondary cytoreductive surgery is a safe procedure which should be offered to recurrent ovarian cancer patients with apparently isolated and resectable disease, and without ascitis. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:185 / 188
页数:4
相关论文
共 16 条
[1]  
BEREK JS, 1983, OBSTET GYNECOL, V61, P189
[2]  
EISENKOP SM, 1995, CANCER, V76, P1606, DOI 10.1002/1097-0142(19951101)76:9<1606::AID-CNCR2820760917>3.0.CO
[3]  
2-H
[4]  
GERSHENSON DM, 1989, OBSTET GYNECOL, V73, P709
[5]   TREATMENT OF RELAPSED CARCINOMA OF THE OVARY WITH CISPLATIN OR CARBOPLATIN FOLLOWING INITIAL TREATMENT WITH THESE COMPOUNDS [J].
GORE, ME ;
FRYATT, I ;
WILTSHAW, E ;
DAWSON, T .
GYNECOLOGIC ONCOLOGY, 1990, 36 (02) :207-211
[6]  
JANICKE F, 1992, CANCER-AM CANCER SOC, V70, P2129, DOI 10.1002/1097-0142(19921015)70:8<2129::AID-CNCR2820700820>3.0.CO
[7]  
2-U
[8]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[9]   Platin-based chemotherapy and salvage surgery in recurrent ovarian cancer following negative second-look laparotomy [J].
Landoni, F ;
Pellegrino, A ;
Cormio, G ;
Milani, R ;
Maggioni, A ;
Mangioni, C .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1998, 77 (02) :233-237
[10]  
MANTEL N, 1959, J NATL CANCER I, V22, P719